GALANTAMINE® (Nivalin, Razadyne, Razadyne ER, Reminyl, Lycoremine) is the medication that is indicated to treat mild to moderate dementia related to Alzheimer's disease, as well as other memory disorders of vascular origin. It improves memory, awareness and mental alertness, slows cognitive decline in people with Alzheimer's. Galantamine Kanon is also able to treat neurological conditions such as post-polio paralysis and myasthenia gravis, and relieve neuromuscular ailments, such as neuritis and neuralgia. It belongs to the group of alkaloids obtained from the bulbs and flowers of Galanthus caucasicus and works by restoring the optimal balance of the neurotransmitters in the brain.
GUARANTEE & EXPIRY DATE
100% Original from the Russian Canon Pharma http://www.canonpharma.ru/.
All packs are air tight sealed and expire up to 05.2027.
Galantamine is a selective, competitive and rapidly reversible inhibitor of acetylcholinesterase. It works by stimulating nicotinic receptors and increasing the sensitivity of the postsynaptic membrane to acetylcholine. It facilitates the transmission of excitation in the neuromuscular junction and restores neuromuscular conductivity in the case of its blockade by non-depolarizing muscle relaxants. Galantamine increases smooth muscle tone, increases the secretion of digestive and sweat glands, causes cramps. By increasing the activity of the cholinergic system, Galantamine improves cognitive function in patients with dementia related to Alzheimer's disease, but does not affect the development of the disease
PACKAGING & DOSAGE
Galantamine comes in the form of tablets. Each tablet contains active ingredient - galantamine hydrobromide, equivalent pure galantamine - 8 mg.
For oral intake.
The average daily dose is 8-32 mg divided into 2-4 intakes.
Myasthenia gravis: the daily dose is divided into 3 intakes.
Alzheimer's disease: treatment is recommended to start with 4 mg two times a day. Within four weeks the daily dose can be gradually increased to 8 mg two times a day - in the morning and evening. Intake the tablets with sufficient water.
If during treatment you must discontinue intake of Galantamine, the restoration of treatment should be started with the lowest dose and then gradually increased.
Patients with moderate hepatic impairment and renal function: initial dose - 4 mg once a day, which is taken in the morning for at least one week, after which the dose is increased to 4 mg two times a day for 4 weeks. The total daily dose should not exceed 12 mg.
Children (over 9 years old)
Treatment of polio and cerebral palsy:
From 9 to 11 years: daily dose - 4-12 mg, divided into 2-3 intakes.
From 12 to 15 years: daily dose is 4-16 mg divided into 2-4 intakes.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Galantamine.
|The purpose of the medication||Nervous System Treatment|